Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 1999

View Archived Issues

Nephrin plays a key role in kidney filtration

Allelix presents third-quarter highlights

Fujisawa launches Prograf in China

AxyS Advanced Technologies enters agreement with Daiichi

Zeffix causes seroconversion in up to 65% of patients with chronic hepatitis B

AdProTech presents data on its membrane-active complement inhibitor

BTG acquires technology for cytokine inhibition

Ramoplanin successfully completes phase II as VRE therapy

Clinical trial program for daptomycin updated by Cubist

Recently issued patent covers Sanofi-Synthelabo's new M3 antagonists

Novel antidiabetic pyridines and pyrimidines described by Novo Nordisk

Two new drugs added to the R&D pipeline at Glaxo Wellcome

Dihydrobenzofuran bronchial therapeutics in development at Byk Gulden

New coagulation factor inhibitors under study at Merck KGaA

Bispidine compounds suitable for Rx of atrial and ventricular arrhythmias

Another series of apoptotic agents designed under Cell Pathways, U. of Arizona collaboration

Klinge focus continues on novel antitumor/immunosuppressive compounds

Merck pulls out of OTC joint venture in Japan

First clinically evaluated ribozyme-based product proves safe in volunteers and patients

Novel opioid analgesic HS-599 operating at the spinal level presented in Budapest

Prophylactic DNA tuberculosis vaccine is also curative in mice

Taiwan university researchers describe pharmacological profile of new adenosine agonist KMCP-981121

New non-narcotic analgesic/antiinflammatory agent emerges from Ukraine

SmithKline Beecham files for approval of first-ever pentavalent vaccine

Nortran reports progress on novel approach to the treatment of ischemic arrhythmias

SB identifies nonprodrug integrin antagonist with excellent oral bioavailability

Potential new diuretic agents selected for detailed biological evaluation at Wakamoto

New label sought for Enbrel in early, active RA

Clinical trials of (+)-calanolide A in HIV-positive patients expanded to Malaysia & Singapore